-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
HIV-1-inhibitor-8
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/hiv-1-inhibitor-8.gif)
| Category | Human immunodeficiency Virus (HIV) |
| Description | HIV-1 inhibitor-8 is an orally active, low-toxicity and potent HIV(cid:0)1 non-nucleoside reverse transcriptase inhibitor (NNRTI). |
Product Information
| Synonyms | HIV-1 inhibitor-8|CHEMBL4848008|BDBM50574913|HY-132291|CS-0200312 |
| Molecular Weight | 439.53 |
| Molecular Formula | C25H21N5OS |
| Canonical SMILES | CC1=CC(=CC(=C1OC2=NC(=NC3=C2CSCC3)NC4=CC=C(C=C4)C#N)C)C=CC#N |
| Purity | 98.03% |
| Solubility | In Vitro: DMSO : 50 mg/mL(113.76 mM;Need ultrasonic) |
| Appearance | Light yellow to light brown (Solid) |
| Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
| Complexity | 736 |
| Exact Mass | 439.14668148 |
| PSA | 40.46000 |
| Target | HIV |
| Vapor Pressure | 8.84E-10mmHg at 25°C |
| XLogP3-AA | 5.1 |
